Delivery Order SPE2DB22D9205-SPE2DB24FZF87
Award Date
1/29/24
Potential Completion Date
2/20/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $29,846.64 and a completion date of March 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, primarily the...
The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. This delivery order is valued at $4,974.44 and has a completion date of January 29, 2024. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of Defense and its...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML. The $24,872.20 order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued up to $4,999,999, to fulfill recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group is a leading...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of EXPAREL 1.3% 20ML 10S. The contract, valued at $14,923.32, has a completion date of May 16, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $2,855.66, has a completion date of February 14, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supplies a variety of pharmaceutical and medical products to the Department of Defense under multiple contracts and indefinite delivery vehicles. This delivery order is...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 266 mg/20 ml vials of the pharmaceutical product EXPAREL. The $3,081.15 contract has a completion date of March 21, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that has numerous prime and subcontracts with the Department of Defense and Department of Veterans Affairs to supply a wide range of pharmaceutical...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of EXPAREL 1.3% 20ML 10S pharmaceutical products. The potential value of the order is $7,464.33 with a completion date of January 25, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, with the Defense Logistics Agency valued up to $4,999,999 through...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The $23,490.24 contract has a completion date of March 12, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds a larger indefinite delivery contract with the Defense Logistics Agency to deliver a broad range of pharmaceutical items, including...
The Defense Logistics Agency has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The contract has a potential value of $8,442.96 and a completion date of January 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to deliver EXPAREL 266 MG/20 ML VIAL 20ML. The firm fixed-price contract has a potential value of $29,846.64 and a completion date of March 7, 2024. This delivery order is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, which enables DLA to issue orders for a wide range...